← All Zenas Biopharma, INC filings

Zenas Biopharma, INC Form 4 insider transactions

NASDAQ
ZBIO
Zenas Biopharma, INC
Form 4: Zenas BioPharma Executive Acquires Stock Options
Joseph L. Farmer, President and COO of Zenas BioPharma, reports the acquisition of stock options.
NASDAQ
ZBIO
Zenas Biopharma, INC
Form 4: Zenas BioPharma Executive Acquires Stock Options
Jennifer A. Fox, Chief Business Officer and Chief Financial Officer of Zenas BioPharma, acquired stock options for 155,000 shares on September 12, 2024.
NASDAQ
ZBIO
Zenas Biopharma, INC
Form 4: Zenas BioPharma CEO Reports Conversion of Preferred Stock and Option Grant Following IPO
CEO Leon O. Moulder Jr. reports the automatic conversion of preferred stock to common stock and the grant of stock options following Zenas BioPharma's initial public offering.